Sativus Tech Boosts Company Profile with Appointment

  • Tal Wilk-Glazer named CEO and Board Director of Sativus Tech.
  • Moshe Bar Siman Tov is leaving the board of directors of Sativus Tech before being named head of the health insurance division of Clal Insurance.

Tel Aviv, Israel, April 6, 2022 (GLOBE NEWSWIRE) — Sativus Tech Corp (OTC: SATT), an AgTech company that develops protocols for growing saffron and other low-yielding food products using advanced vertical farming technology, today announced that Tal Wilk-Glazer has was named CEO of the company effective April 4, 2022. Wilk-Glazer will also join the company’s board of directors assuming the role of director. Moshe Bar Siman Tov recently announced his departure after being named head of the health insurance division of Clal Insurance. Bar Siman Tov led Sativus Tech’s strategic discussions and played an important role in shaping the company’s positioning in the pharmaceutical and dietary supplement sectors. Iris Ginsburg is also leaving the board to pursue another role.

“Sativus Tech is at the forefront of one of AgTech’s most innovative breakthroughs,” said Wilks-Glazer. “Advancing the company’s mission is important as the global community seeks alternatives to agriculture to serve the consumer, as well as the pharmaceutical and nutraceutical industries. I am honored to be the new CEO of Sativus Tech and look forward to working with the team to build on the strong foundation that has been established.

Tal Wilk-Glazer became CEO of Sativus Tech’s subsidiary, Saffron Tech, in December 2021. In that short time, she managed to establish the company’s first operational R&D facility in southern Israel. It has also entered into a joint venture with Naveh Pharma to develop and distribute food supplements and beauty products based on saffron.

“We welcome Tal as CEO of Sativus Tech and as a strategic addition to our Board of Directors,” said Avi Stern, Chairman of the Board of Sativus Tech. “We look forward to leveraging his leadership and entrepreneurial experience to advance our business and expand our offerings to the global community. We are now well positioned to establish our first fully operational and revenue-generating facility in 2023. I thank Moshe Bar Siman Tov and Iris Ginsberg for their valued services to the Board of Directors and wish them success in their new ventures.

About Sativus Tech Corp:

Sativus Tech Corp (OTC: SATT) is an AgTech company that uses advanced vertical agricultural technology to increase the production of low-yielding food products in the global market. The company focuses on the research, development and marketing of agricultural products that are in high demand but scarce in the market. A reliable supply of these highly coveted food products can be used in a variety of applications including the pharmaceutical, nutraceutical, culinary and beauty industries.

Sativus Tech Corp subsidiary Saffron Tech is revolutionizing the AgTech world by creating the protocols for growing saffron on indoor vertical farms. It also increases the production of the spice by multiplying the number of annual harvests. Sativus Tech Corp’s technology offers a responsible and sustainable way to grow crops in a world facing environmental challenges and dwindling soil supplies, dwindling water sources and unstable weather conditions.

Caution Regarding Forward-Looking Statements
This letter contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on management’s current beliefs and expectations and are subject to substantial known and unknown risks and uncertainties that could affect our future results. , performance or achievements differ materially from those expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include the risks discussed in our quarterly reports on Form 10-Q and our annual report on Form 10-K, including in the sections captioned “Risk Factors” and “Statements prospective”. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to place undue reliance on these forward-looking statements.

Investor Relations:

Gadi Levin

(800) 608-6432

Press inquiries:

[email protected]


Comments are closed.